If you read the investor presentation these shares released in July are performance based as another poster pointed out and they cannot be sold until they achieve 20m revenue or FDA approval so in reality none of those shares can be sold on market until probably October/November 17 onwards when FDA approval happens...
Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-137
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)